The Clinical Role of OKT3
- 1 February 1990
- journal article
- Published by Elsevier in Cardiology Clinics
- Vol. 8 (1) , 97-105
- https://doi.org/10.1016/s0733-8651(18)30386-2
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- EFFICACY OF OKT3 MONOCLONAL ANTIBODY THERAPY IN STEROID-RESISTANT, PREDOMINANTLY VASCULAR ACUTE REJECTIONTransplantation, 1988
- OKT3 monoclonal antibody in pediatric kidney transplant recipients with recurrent and resistant allograft rejectionThe Journal of Pediatrics, 1987
- Comparison of Antimouse and Antihorse Antibody Production during the Treatment of Allograft Rejection with OKT3 or Antithymocyte GlobulinNephron, 1987
- OKT3: First-Dose Safety and SuccessNephron, 1987
- The Human Immune Response to the OKT3 Monoclonal Antibody Is OligoclonalScience, 1986
- A Randomized Clinical Trial of OKT3 Monoclonal Antibody for Acute Rejection of Cadaveric Renal TransplantsNew England Journal of Medicine, 1985
- A Prospective Clinical and Immunologic Analysis of Patients with Serum SicknessNew England Journal of Medicine, 1984
- Unusually restricted anti‐isotype human immune response to OKT3 monoclonal antibodyEuropean Journal of Immunology, 1984
- REVERSAL OF TRANSPLANT REJECTION BY MONOCLONAL ANTIBLAST ANTIBODYThe Lancet, 1983
- OKT3 monoclonal antibody inhibits cytotoxic T lymphocyte mediated cell lysisInternational Journal of Immunopharmacology, 1981